Matt's Take Matt's Take February 14, 2025 STAT Plus: How Trump’s ‘fear factor’ is already reshaping American science
Matt's Take Matt's Take February 4, 2025 STAT Plus: Merck’s earnings miss focused attention on Gardasil. The real issue is Keytruda
Matt's Take Matt's Take November 23, 2024 STAT Plus: Prognosis: Under Trump, the CDC is in big trouble, but the FDA might be OK
Matt's Take Matt's Take November 22, 2024 STAT Plus: What could Trump mean for the business of health? Scenarios for an RFK Jr. HHS